Home » Rockwell Automation Releases FactoryTalk Pharma Suite 2.1 Software
Rockwell Automation Releases FactoryTalk Pharma Suite 2.1 Software
PharmaManufacturing.com
08/25/2010
Rockwell Automation today announced the release of its FactoryTalk Pharma Suite 2.1 software. FactoryTalk Pharma Suite applications now incorporate electronic batch recording (EBR) capabilities, and are tailored to the needs of pharmaceutical and biotech manufacturers. The new release continues the tradition of innovations that set Pharma Suite apart, and extends its capabilities in supporting a true “review-by-exception” methodology.
With Pharma Suite 2.1 exceptions during batch recording can be reviewed and addressed in real-time, not after the fact, as is typical for paper-based or “paper-on-glass” workflows. The exception handling during the EBR execution occurs during the manufacturing process, allowing the operator on the shop floor to address exceptions as the manufacturing rules are enforced in real-time. This reduces wasted time, money and materials.
New usability capabilities also allow quality personnel to start investigating process deviations as they occur on the shop floor, rather than wait for batch completion. Collected exceptions are the starting point for the batch review process. The online batch record review capability allows quality control personnel to more efficiently judge the documented deviations and to close out the review process more quickly and with fewer process deviations.
The new EBR capability reduces the amount of time spent on batch review after completion of the batch, which means the finished products spend less time warehoused waiting for the release. This reduces inventory costs, increases turnover and allows the product to spend more time in the distribution channel before its shelf life expires.
All quality-related processing information is compiled in a holistic batch record based on the ISA S88 standard. Pharma Suite also provides the capability to render batch record information in different publishing formats like PDFs, HTML, XML and classic paper-based reports.
Rockwell Automation recently presented these new capabilities at its 11th Annual International Life Sciences Symposium in Montpellier, France. The event brought together senior managers from the world’s top 50 pharmaceutical companies and gave them an opportunity to network, share best practices and learn more about the latest industry trends. Attendees applauded the new capabilities including the use of role-based views and reports, the ease of system usability, the adaptation of industry standards and the ease of deployment.
“Pharma Suite 2.1 is the next logical step to break the old ‘paper-on-glass’ paradigm,” said Martin Dittmer, FactoryTalk Pharma Suite product manager, Rockwell Automation. “For years, EBR has been interpreted as putting the old paper system behind computer screens; however, computer-based systems are capable of much more. Pharma Suite continues to incorporate new and exciting capabilities to assist our customers in accelerating their innovation and shortening time to market. Pharma Suite is optimized to help users maximize their productivity at each step of the recipe lifecycle from recipe design to execution, review and approval.”
In Pharma Suite, recipes are modeled graphically and aligned with the ISA S88 standard. Visual tools and intelligent search mechanisms help ensure that all information required for recipe design can be accessed quickly and easily. Recipes are assembled from reusable parameterized building blocks that represent standard functions such as adding material to a process or checking equipment against requirements. Pharma Suite also allows the reuse of pre-configured building blocks to accelerate recipe design, reduce errors and speed validation, resulting in faster deployment.
The recipe execution client of Pharma Suite maximizes operator efficiency by focusing on the operator’s main workflow. The system guides the operator through complex processes and helps ensure that all tasks are completed according to the recipe. Deviations are handled by the built-in exception management that delivers important input for review by exception.
Pharma Suite is based on the state-of-the-art FactoryTalk ProductionCentre manufacturing operations platform, which is proven in hundreds of installations across different industries and scales of deployments. It leverages a service-oriented architecture for cost-effective, flexible deployment, as well as integration with business and automation systems. Its object-oriented design makes it easier and faster to build, modify and systematically deploy applications across multiple sites.
For additional information on Rockwell Software solutions for the life sciences industry, please visit http://www.rockwellautomation.com/rockwellsoftware/lifesciences/.
More News:
-
02/09/2012
Watchdog Fines Ernst & Young $2 million Over Medicis Pharma Corp. AuditsFrom Reuters.com
The watchdog board for corporate auditors on Wednesday said it has imposed a $2 million penalty, its largest fine ever, on accounting and consulting firm Ernst & Young LLP in a settlement involving past audits of Medicis Pharmaceutical Corp.
-
02/09/2012
FDA Issues Draft Guidance on Biosimilar Product Development
The U.S. Food and Drug Administration today issued three draft guidance documents on biosimilar product development to assist industry in developing such products in the United States.
-
02/08/2012
Biomedical Industry Loses Momentum in California, According to 2012 Report
Innovation slows as productivity in the Biomedical industry declines
-
02/02/2012
Pfizer Baby Boom? Pfizer's Official StatementFrom Pharmalot.com
About nine months from now, a new phenomenon may appear at a hospital near you: the Pfizer baby. Why? The drugmaker has taken the embarrassing step of recalling 1 million packets of birth control pills due to a packaging error. Hear EVP and CMO, Freda Lewis-Hall's read Pfizer's official statement.
-
02/02/2012
News: AstraZeneca To Cut 7,300 JobsFrom MarketWatch.com
Drug firm AstraZeneca on Thursday said it would cut approximately 7,300 jobs as part of an ongoing initiative to reduce costs and drive innovation.
-
02/01/2012
Pfizer Recalls 1 Million Birth Control Packs for Error That Could Cause Unintended PregnancyFrom WashingtonPost.com
Pfizer Inc. is recalling 1 million packets of birth control pills due to a packaging error that could raise the risk of an accidental pregnancy by leaving women with an inadequate dose. The problem affects 14 lots of Lo/Ovral-28 tablets and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets. Both products are manufactured by Pfizer and marketed in the U.S. by Akrimax Rx Products under the Akrimax Pharmaceuticals brand.
-
01/26/2012
News: Abbott Labs Cuts 700 Manufacturing JobsFrom WashingtonPost.com
Medical device and drugmaker Abbott Laboratories said Wednesday it will lay off 700 employees as part of ongoing restructuring efforts. A company spokeswoman said most of the layoffs will affect employees who manufacture the company’s heart stents and diagnostic tests.
- 01/24/2012 ISPE Announces 2012 FOYA Winners
- 01/24/2012 Genzyme Gains Approval for Framingham Site, a Boost to Fabrazyme Production
-
01/19/2012
Big Pharma Execs May Wish They'd Never Heard Of Paula DeenFrom Forbes.com
Novo Nordisk has nabbed Paula Deen as a new spokeswoman to help raise awareness about type 2 diabetes. Many in the drug industry wish it weren’t so, but without major legal and regulatory changes, such matches between celebs and drug firms are as certain as the sun rising in the east.
- All news »
Get Connected Now!
- Featured White Papers

Print page